4
Changes in Ownership
Climb Bio, Inc. Filed Acc 0001193125-26-082533
Director sold 50,000 shares at an average $7.01 ($350,253)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Thomas Stephen Basil · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-02-25 | Sale : show line 1 in the form 10b5-1 | −33,687 | $7.00 | $235,964 | 170,970 | D |
| 2026-02-26 | Sale : show line 2 in the form 10b5-1 | −16,313 | $7.01 | $114,289 | 154,657 | D |
| Open-market sales · 50,000 sh · avg $7.01 · $350,253 | ||||||
Loading xslF345X05/ownership.xml…